- Research works
- 1 fractional, all time
- Citations
- 19 32.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Fondazione Cariparma is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Fondazione Cariparma publish most on?
By volume: Chemokine receptors and signaling, Nonmelanoma Skin Cancer Studies, Lung Cancer Treatments and Mutations and Acute Lymphoblastic Leukemia research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chemokine receptors and signaling Oncology 0 works
- 2 Nonmelanoma Skin Cancer Studies Epidemiology 0 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 4 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 5 Carcinogens and Genotoxicity Assessment Cancer Research 0 works
- 6 Cutaneous Melanoma Detection and Management Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Parma
- University of Parma
- Ospedale di Parma
- Consorzio Nazionale Interuniversitario per le Telecomunicazioni
- Institute of Materials for Electronics and Magnetism
- European Food Safety Authority
- Chiesi (Italy)
- Experimental Station for the Food Preserving Industry
- Azienda Unita' Sanitaria Locale di Parma
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.